GB2178447A - A matrix for cell cultivation in vitro - Google Patents

A matrix for cell cultivation in vitro Download PDF

Info

Publication number
GB2178447A
GB2178447A GB08614799A GB8614799A GB2178447A GB 2178447 A GB2178447 A GB 2178447A GB 08614799 A GB08614799 A GB 08614799A GB 8614799 A GB8614799 A GB 8614799A GB 2178447 A GB2178447 A GB 2178447A
Authority
GB
United Kingdom
Prior art keywords
matrix
cells
fibers
cell
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08614799A
Other versions
GB2178447B (en
GB8614799D0 (en
Inventor
Zvi Bohak
Avinoam Kadouri
Martin Sussman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of GB8614799D0 publication Critical patent/GB8614799D0/en
Publication of GB2178447A publication Critical patent/GB2178447A/en
Application granted granted Critical
Publication of GB2178447B publication Critical patent/GB2178447B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10Perfusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14Scaffolds; Matrices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers
    • C12N2533/32Polylysine, polyornithine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nonwoven Fabrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)

Abstract

A matrix and cultivation system for anchorage dependent cells has a substantially increased available effective surface area for cell attachment provided by a fiber network or open-pore foams with suitable pore size of 10 mu to 100 mu . Attachment of the cells can be enhanced by modifying the surface of the substrate. One embodiment comprises a matrix in particle or flake form.

Description

SPECIFICATION A matrix for cell cultivation in vitro Field of the invention The present invention relates to the in vitro cultivation and growth of various of living cells, and in particular to methods and devices for in vitro growth of mammalian tissue cells that require (in addition to sterile liquid nutrient media) attachment to a solid surface in order to effectively grow, metabolize nutrients, reproduce, and produce biologically active materials. Such tissue cells are called "anchorage dependent" cells. The provision of suitable surfaces to which such cells will attach themselves, is an essential requisite for their in vitro cultivation.
Background of the invention Tissue cell culture is therefore carried out on solid continuous surfaces. On laboratory scale these are in the form of petri-dishes, flat sided bottle or roller bottles. Recent improvements, applicable also to large scale culture have been the development of spheres of various sizes such as microbeads, as well as of ceramic blocks traversed by small rectangular channels. In all these devices the cells adhere and propgate on the available surface of a solid.
Cells will attach only to surfaces that have suitable surface compositions and an electrical surface charge.
Materials that have proved successful for this purpose are glass, ceramics, polyvinyl chloride, polystyrene, dextran, collagen, and certain other materials. Frequently the cell attachment surfaces of such materials are treated with 95% sulfuric acid, or preferably with a corona or oxygen plasma discharge to improve cell adherence. Under culturing conditions such as those described in (Kruse & Patterson Tissue Culture - Methods and Applications, Academic Press 1983), cells coming in contact with these surfaces will attach themselves to the surface, and reproduce until they cover the surfaces in a contiguous, confluent monolayer. On reaching confluence cell growth ceases. The phenomenon of cell growth cessation when a contiguous layer of cells is achieved is called "contact inhibition" and is a characteristic of non-cancerous cell growth on two dimensional surfaces.
The growth surfaces used at present for in vitro tissue culture suffer from certain serious shortcomings: a) They provide limited area per unit volume of nutrient medium supplied, so that the number of cells that can be grown per unit volume of nutrient medium is as much as three orders of magnitude smaller than the volumetric densities of cells in in vitro tissue.
b) They require high concentrations of inoculated cells in order to initiate cell growth. Typically cells are introduced to a fresh culture surface at a concentration and number which is 20-30% of the final number reached at confluence and it is usually impossible to inoculate with less then 10% of the number reached at confluence.
c) Cell growth of non-cancerous cells limited to monolayers; d) Cells tend to detach from their anchorage surface under conditions that include: monolayer saturation; high or low serum concentration; medium depletion, and particularly, viscous shear caused by stirring or perfusion of the culture medium. Cell growth and biosynthesis stop on cell detachment.
Though non cancerous cells are grown on two dimenisonal surfaces, it has long been known that normal cells will also grow in gels, and specifically those of collagen. One such gel is available commerically (trade name "Gelfoam", Upjohn, Kalmazoo). Gels have however a poor dimensional stablility and, due to their internal structure are unsuitable for growing cells to a reasonable density and especially not for systems with medium perfusion. They have therefore not found use for the large scale culture of cells. Their use in limited to laboratory studies of cell morphology, or studies of the "hystotypic" growth of primary cultures (e.g. Dougles et al., In Vitro, 16, 306-312 (1980)).
Also relevant to this invention is the fact that certain cells and particularly cancerous mammalian cells and altered forms of cells such as hybridomas can be grown freely suspended in culture medium or immobilized in small beads of porous gelled material such as carrageenan, agarose, collagen, gelatin and similar starch or protein or polymer materials. Cells may be mixed into such gels prior to casting the gels into the form of small beads or particles that will be suspended in nutrient medium. (Karkare, S.B., Phillips, P.G., Burke, D.H., and Dean Jr., R.C.
"Continuous Production of Monoclonal Antibodies by Immobilized Hybridoma Culture" A.C.S. Annual Meeting Phila. Pa, Aug 27, 1984, available from Verax Corp. Hanover, N.H.).
Alternatively, cells may be immobilized in microcapsules as described by Lim et al., Microencapsulation of Living Cells and Tissues; J. Pharm. Sci., 70, 4: 351-354, April 1981; Nilsson., Entrapment of Animal Cells for Production of Monoclonal Antibodies and other Biochemicals, Nature 302, 629-630, 1973.
The invention herein described also relates to the cultivation of such non-anchorage dependent cells and other cells whose growth and harvesting may be facilitated by some form of immobilization as described above.
Summary of the invention According to the present invention htere are provided: A matrix for use in cell cultivation in vitro providing a high-surface-area substrate the effective area of which is from 10 to about 100 times the area of same projected onto a plane surface, comprising a physiologically acceptable network of fibers having a porosity of from 40 to about 95% and a pores size of the order of 10 p to 100 p, or an open-pore foamed structure with a pore size of from about 10 p ot 100 p, the overall height of the matrix being of the order of from 50 p to about 500 p; A matrix where the 3-dimensional structure is one of a non-woven fabric from round, flat, non-round, or hollow fibers or combination of such fibers of the order of from 0.5 pm to 50 pm diameter or width;; A matrix where the structure is composed of ribbon formed fibers of 2 um to 20 pm width which may be crimped, and where the ratio of width to thickness is 2:1 or more; A matrix for anchorage dependent cell attachment that has a high surface density by which is meant a high specific surface area, or surface area per unit of projected surface or, high surface area per unit volume of surrounding medium; A surface that increases the density of cells grown per unit volume of medium by at least one order of magnitude greater than that achievable in flat plate cultures; A high specific surface cell attachment matrix that may be disposed as a flat sheet; A matrix that may be disposed as a spiral sheet or as corrugated sheets.; A matrix that may be disposed as suspended cell carrier in a stirred culture tank reactor; A matrix that can be easily sampled for determining cells numbers;; A matrix that can be easily samples for microscopic examination; A matrix that protects cells from impact and viscous shear; A matrix that inhibits detachment of cells from said surface; A matrix that permits cell growth to be initiated at low inoculation densities, and consequently permits cell densities and number to increase by more than 10 fold, thus reducing the number of cultures that need to be started to achieve high production of cells and cell products; A matrix that permits cell growth in multiple layers and in a three dimensional matrix; A matrix that permits cells to grow in three dimensional non-planar forms; A matrix that allows rapid inward diffusion of materials such as nutrients, hormones, growth factors and serum components and outward diffusion of metabolic wastes and cell products;; A matrix for growing anchorage-dependent or non-anchorage dependent cells, said matrix providing high internal surface area and high internal volume with pores that are 1 to 20 times the volume of individual cells, said pores being within 100 micrometer of the exterior surface of the matrix so as to provide rapid diffusion throughout and into and out of the matrix; A matrix for entrapping cells that are not anchorage-dependent, that facilitates the harvesting of such cells in suspension culture; A matrix for protecting and growing non-anchorage dependent cells at high density while exposed to fluid nutrients that are moving at high velocities and that are under high shear; A matrix for entrapping or anchoring cells that has a near neutral buoyancy so that particles made of this matrix may be suspended in nutrient medium with minimal amounts of stirring;; A matrix for anchoring or entrapping cells that has a variable buoyancy controlled by the pressure imposed on the cell culture vessel, so as to permit moving the matrix up and down through the nutrient liquid by lowering or raising the pressure in the cell culture vessel; A process for producing tissue plasminogen activator at high concentrations and in large volumes of culture, while conserving serum and preventing dilution of cell products in excess medium, and means for carrying our such process.
These and other objectives will became apparent from the following detailed disclosure.
General description of the invention According to the invention there is provided a growth matrix that substantially increases the available attachment surface for the adherence of the cultivated cells: the increase is by a factor of from 10 to 30 times, calculated on the projection of the base on which structures of the invention are supported. Such an increase by a factor of 10 to 30 times, is per unit layer, and if a plurality of such layers, separated by spacers or the like, is used, the factor of 10 to 30 times applies per each such structure.When the matrix is used in sheet form, preferably non-woven fiber sheets, or sheets of open-pore framed polymers, the preferred thickness of the sheet is about 50 to 250 pom, there being provided adequate porosity for cell entrance, entrance of nutrients and for removal of waste products from the sheet said pores having an effective diameter of 10 pm to 100 vim. Such sheets can be be prepared from fibers of various thicknesses, the preferred fiber thickness or fiber diameter range being from 0.5 um to 20 pm, still more preferred being in the range of 10 pm to 15 pm diameter.
A plurality of such sheets can be used, stacked above each other, and in such case suitable spacing means are resorted to. A porous spacer of from 150 um to about a millimeter generally gives satisfactory results.
The structures of the invention may be supported by, or even better bonded to, a porous support sheet or screen providing for dimensional stability and physical strength.
Such matrix sheets may also be cut, punched, or shredded to provide particles with projected area of the order of about 0.2 mm2 to about 10 mm2, with the same order of thickness (about 50 to 250 pom), said particles being particularly useful in suspension of fluidized culture.
The present invention relates also to devices or matrices for entrapping and growing non-anchorage dependent cells in open encapsulation, providing a protected micro-environment for growth of cells and facilitating cell harvest.
To produce large quantities of non-anchorage dependent cells, the cells are usually grown in suspension in a nutrient liquid medium that is stirred to ensure that each cell is adequately bathed in nutrients, and that metabolic wastes are carried away from the cell. A certain fraction of the cells is destroyed by impact with the impeller or by high shear. Harvesting cells from conventional suspension culture requires special supplemental equipment such as centrifuges or micro-porous filters. Also cell concentration per cubic centimeter of nutrient liquid is relatively low.
One method of simplifying the harvesting of such cells and increasing their density involves encapsulating the cells in permeable microcapsules as described by the preciously cited works of Lim and Nilsson. These microcapsules are larger and denser than the cells they entrap. Consequently they are easily separated from the nutrient medium by settling or by filtration. The microcapsules have certain disadvantages: - they are costly and delicate to produce; - at high density growth, cells at the center of the capsule frequently die; - capsules may burst prematurely losing their content cells.
- each new inoculation requires a fresh encapsulation procedure.
The present invention pertains to the provision of forms of materials that provide improved surfaces and morphologies for cell attachment and/or entrapment during in vitro culture, said improved surfaces and morphologies overcoming the shortcomings of currently used attachment surfaces, as well as providing new capabilities for improved culture of other cells not requiring an anchorage surface.
Porous sheets as cell growth matrices We have found that certain forms and composition of fibers and certain high porosity membranes provide highly effective supports for culturing cells and particularly anchorage dependent cells; particularly when said fibers are arranged in flat, highly porous, non-woven sheets, or mats, having an appearance like filter or tissue paper, or of thin porous felt. Said non-woven sheets can be made by any of the wide variety of well known techniques for making non-woven fabrics, papers, or felts, which include spin-bonding, thermal bonding, calendering, needling, etc., techniques. The sheets should preferably be free of glue or adhesive coatings not specifically used to promote cell adhesion to the fiber surfaces.
The fibers used to form the non-woven fiber sheets may be in the form of continuous filaments, staple filaments, hollow filaments, pulp, or floc, or combinations of such forms, and are preferably disposed in the sheet in a highly disordered, random-like, intertangled, manner; the axes of the fibers forming an open, multi-dimensional array. The porosity of the sheet should range from 40 to 95% with a preferred porosity of 60-80%. Preferred pore-size is between 10 and about 100 pom.
The individual fibers should have deniers (weight in grams of 9000 meters of fiber) of between 0.05 and 5 denier per filament (dpf) with a preferred weight of 1.0 to 1.5 dpf. Fiber cross-section may be round or not, with a preferred cross-section being that of a ribbon, that may in addition have a crimp imposed along its axis. Fiber width may range from 0.5 to 50 micrometers, but a preferred width is 10 to 15 micrometers. When hollow filaments are incorporated in the non-woven sheet, they may have single or multiple lumens and their denier will generally be greater than solid cross-section fiber, ranging as high as 50 denier per filament.
High porosity membranes suitable for this application must have a sponge-like structure and porosity, and pore dimensions similar to the non-woven fiber mats; that is 40 to 95% porosity and pore size between 10 and 80 micrometers. Pores must be opened and have high tortuosity. The polymer matrix should be continuous and can have any composition that promotes cell adhesion. Examples of polymers suitable for porous membrane growth are cellulose, cellulose acetate, polyethylene, polyesters, polyfluorochloroethylenes, polyvinylchlorides, polystyrenes, polysulfones, fiber glass, etc.
The thickness of the non-woven fiber sheet or porous membrane is an important parameter. Under proper culture conditions many cells inoculated on these sheets grow within the thickness of the sheet, rather than on the top surfaces of the sheet. Cells proliferate among the fibers of the sheet in three dimensions, rather than in two dimensions as in conventional tissue culture bottles, flasks, petri dishes and on microcarrier beads. Cells may attach themselves to more than one fiber (Figure 1) and cell growth thus takes place in the internal volume of the fiber matrix. The cells form a multilayered tissue-like structure whose thickness is that of the non-woven fiber sheet.To ensure adequate diffusion of nutirents and products to and from the interior of the cell aggregate and to prevent necrosis of cells in the interior of this dense structure, the sheet must be between about 25 and 250 vim thick. A preferred thickness is 100-150 pm. An ideal sheet thickness is approximately equal to the spacing of capillaries that occurs in vivo in the particular kind of tissue being cultured.
The non-woven porous growth matrix sheets may be used alone or they can be thermally bonded to rigid support materials that help the sheets retain their shape, or prevent the sheets from settling into dense contact with each other when used in a close packed array. A particularly useful configuration is to thermally laminate the growth matrix sheet to coarse (1 mm mesh) polypropylene screen (Figure 2). This also allows adjustment of the net density of the matrix so that it can be neutrally buoyant when used in a suspension culture.
The growth matrix sheets and the support and separator sheets may be provided with means to distribute liquid medium uniformly to all parts of a stack of such sheets and with means to promote the flow of medium parallel to the plane of each matrix sheet. Such means may be integral baffles or channelling orifices as shown by 20, and 21, in Figure 4a.
Growth matrix sheets can be used in many ways: - as liners on bottoms of petri dishes or on the inside surfaces of roller bottles, increasing growth surface area by more than one order of magnitude; - as spiral sheets inside roller bottles (Figure 3); - as in Figures 6 and 7, as sheets (11) laminated or layered external to and between flattened tubes (13) of permeable or microporous polymers wherein each alternate flattened tube serves as a conduit, the one for liquid nutrient medium (14), the other for gases (15) such as oxygen, air, CO2 and water vapor, the entire assembly being wound into a spiral as shown in Figure 6, or placed in a laminated interleaved stack (Figure 8) and immersed in a closed sterile container (16) Figure 7, filled with nutrient medium (17) and inoculated with cells for cultivation.Gases and nutrient medium are pumped through the flattened permeable tubes in a pulsatile fashion so that cells growing on the porous or non-woven fiber matrix sheet (11) are bathed in gently surging fluid that is never depleted of oxygen or nutrients and in which wastes do not accumulate through stagnation.
Four connections (Figures 6, 7, (18), generally running through the cover (19) of the assembly serve to introduce and remove gases, and nutrient medium to and from the flattened tubes (13). Probes for monitoring culture parameters such as PO2 (10), pH (11) and glucose concentration (12) may be placed in the growth medium (17) external to the flattened spiral tubes and used to control the nutrient (14) flow rate and composition, as well as the gas (15) CO2 and oxygen content. Polypropylene screens or similar spacers (12) are placed inside each flatted tube and between tubes to maintain minimum separation distances between each layer of the spiral or stack.Access to the cell growth matrix (11) and external or immersion growth medium (17) is made through ports (20) that may also be used to perfuse or remove the immersion medium, or for product collection, or for change of medium, or to samples cells.
- as packing in columns that are continuously perfused with medium, (Figure 4); - as microcarriers in suspension cultures replacing such materials as modified dextran beads. (Reference "Microcarrier Cell Culture" Pharmacia Chemicals, Uppsala, Sweden (1981)).
When used as microcarriers or as column packing the growth matrix is advantageously laminated to polyproplyene screen (as previously mentioned (Figure 2) that are then cut into small discs, squares, rings cruciforms, or corrugated and folded shapes, to give desired hydrodynamic characteristics to the packing or suspension material.
Alternatively the growth matrix material when used as microcarriers in suspension culture can be cut from fibrous non-woven sheets composed of mixtures of fibers whose density and relative proportions give the sheet a near neutral buoyancy. As an example, circular microdiscs having a diameter of 2 millimeters were stamped from a non-woven sheet composed of a ramdomly oriented mixture of 20 weight percent polyethylene terephthalate fibers and 80% fibers of polypropyline. Because the polyethylene terephthalate fibers had a specific gravity of 1.33 and the polypropylene fibers a specific gravity of 0.92, the composite non-woven fabric had a density of 1.002, so that microdiscs stamped from this sheet were kept suspended in liquid medium when stirred at much lower speeds then are required to maintain in suspension discs composed of solid polyethylene terephthalate fibers only.
Near neutral buoyancy microdiscs were also made by combining in suitable proportions hollow filament polymer fibers having gas filled lumens, with solid, low denier per filament polymer fibers (Figures 2a, 2b). The advantage of microcarriers bearing entrapped gas bubbles is that their buoyancy can be controlled. Because the volume of the entrapped gas increases or decreases as the external pressure on the suspension culture is decreased or increased, the microdiscs are made periodically to float and sink in the nutrient liquid without using an agitator or stirrer. This produces a very gentle washing action and is particularly effective for bringing nutrients to the surface of growing cells and removing metabolic wastes, with cell types that tend to become dislodged from attachment surfaces when stirred.It also eliminates the need for agitators and stirrers, simplifying and reducing the cost of large culture vessels.
A major advantage of this invention is the application of porous matrix cell attachment surfaces to microcarrier tissue cell "suspension culture" (Microcarrier suspension tissue cell culture procedures are described in "Microcarrier Cell Culture," Pharmacia Fine Chemicals, Uppsala, Sweden, (1981); and in the article "Large Scale Production of Tissue Cells" Scientific American Jan (1983)). For suspension culture application the porous sheet is cut into small pieces, each having a projected surface of between about 1 to 100 square millimeters, with a preferred projected area of about one to 20 square millimeters. The shape of said small pieces may take many forms, with a disc or circular form being preferred.The porous matrix cell attachment sheet material may be thermally bonded to materials such as polypropylene screening having a 1 mm or finer mesh, in order to strengthen the porous matrix material and also in order to increase its buoyancy as described previously. It is particularly advantageous to punch such discs using a heated die so that the fibers at the circumferential edge of the dsic are thermally bonded or partially fused to each other.
We have discovered on theorectical grounds and verified through experiments that such porous matrix microcarriers require substantially lower concentrations of inoculum (cells introduced at the start of a culture) to initiate successful cell growth. For example in a typical suspension culture of microcarriers (modified dextran beads), the inoculum contains 30% of the number of cells that are harvested at the end of the culture (Fleiscschaker, p. 117, Ph.D. Thesis, June 1982, M.I.T. Dept. of Nutrition and Food Science). We have discovered that when polyester fiber porous matrix microcarriers having a total attachment surface area equal to that of the modified dextran microbeads are used, the inoculum cell content need only be less than about 5% of the final number of cells harvested. This reduction in inoculum size is an immense advantage in large scale production of tissue cells and cell products, in that production from a single culture can be increased by a factor of approximately 6 to 10, and contamination and reseeding problems are diminished.
The effectiveness of fiber or porous matrix microcarriers with low concentrations of cell inocula is not obvious, and is an important discovery. The explanation for this superior effectiveness is as follows: In a microcarrier suspension culture, for confluent cell growth to occur on an individual microcarrier particle, a minimum number of inoculum cells must collide with and fix themselves to that microcarrier particle. This minimum number of cells will depend to some extent on the cell type, however a typical number is 7 cells per microcarrier particle. (Fleiscschaker, J., pg 171, Ph.D Thesis June 1982, M.I.T. Dept., of Nutrition (Food Sceince).Because the collisions between microcarrier particles and inoculum cells are purely random processes, the fraction of microcarrier particles (fj) experiencing collisions with any number (i) of cells can be estimated by the Poisson Distribution (Equation I): fj = A(ei (i) ) (I) where i r the number of inoculant cells colliding with a microcarrier particle r average number of inoculum per microcarrier particle, or, inoculum cells per milliliter/microcarrier particles per milliliter If "n" collisions are required to initiate confluent growth, it follows that the fraction (P), of microcarriers experiencing confluent growth will be one minus the fraction of microcarriers having fewer than n collisions.
P= 1 En-1 (f) (II) when n = 7, and 105 cells/ml are inoculated on a normal concentration of 3 x 104 microcarrier bead particles per milliliter, 15 then 2, in equation I, is equal to 3.3 cells/microcarrier particle. From equation (I), the fractions of particles experiencing zero to six collisions are found to be: f,=.O; f, =.12; f,=.20; f, = .22; f,=.18; f,=.12; f,= 0.7; consequently equation (II) becomes: P=1-(f0+f1+f2+f3+f4+f5+f6) = 0.05 meaning that only one particle in 20 will have 7 or more collisions, and experience confluent cell growth. This culture will therefore fail. Such is in fact the general experience when attempting to inoculate conventional microcarrier cultures at these dilute cell concentrations and conditions (Fleiscschaker ibid. pg. 117).
This statistical reasoning explains the striking superiority of porous or fiber matrix microcarriers. Typically such carriers are 2.0 mm diameter microdiscs stamped from a 150 urn thick non-woven sheet composed of 10 urn diameter polyester fibers. The sheet presents an area for cell attachment of more than 3000 cm2/gram of sheet material. A concentration of 50 such microdiscs per milliliter of culture solution furnishes the same cell attachment area as 3 x 104 conventional microcarrier beads per milliliter. At 105 cells/ml inoculant concentration the average number of inoculant cells per microdisc, (2), is now 105/50, or 2000 cells/per microdisc (in contrast to 3.3 cells per microbead).
The collision frequency of a microdisc with these 2000 cells is magnitudes higher than that of a dextran microcarrier bead with its 3.3 cells. In fact insertion of 2 = 2000 in equation (I) shows that disc particles having fewer than even 100 cell collisions are vanishingly rare. Consequently at the same inoculant concentration and surface anchorage area, the probability of a microdisc experiencing more than 100 cell collisions is given by equation II as P is approximately equal to one. Therefore all the microdisc carriers are bombarded with cells and their growth surface reaches saturation on exposure to dilute inocula. Experimentally, 1% inoculation has succeeded in producing confluent growth.
This effect cannot be reproduced with microbeads or non-porous carriers because reducing the number of microbeads reduces the surface available for cell attachment hence microbead suspension culture is limited to a heavy inoculum.
Examples 1. Material to be used for cells culture matrices were first passed through a discharge from a plasma torch and washed with methanol. The materials were sterilized under a UV light then immersed in a solution of 100 lig/ml poly-D-lysine, and rinsed with sterile water. Cell culture was carried out at 37"C, in an atmosphere of 5% CO2 in air.
2. Unwoven sheets of polyester (0.15 mm nominal thickness, 15 urn fibers) or polypropylene (0.15 mm nominal thickness, 12 urn fibers) were cut into 30 mm diameter circles, and laid on the bottom of 30 mm petri dishes.
The same size tissue culture dishes were used as controls. Human dipolid fibroblasts (lung) (1.5 x 105 cells) were seeded in each plate with 2.5 ml of DMEM (Dulbeco modified Eagle's medium) + 10% serum and the progress of the cultures was examined microscopically. It was observed (Figure 1) that the cells formed a multi-layered, tissue like structure. The culture was continued until the cells appeared as a congruent mass, whereupon the number of cells in each plate was determined by measuring the amount of DNA. The results (Table 1) show that 7-10 times more cells were obtained in the polymer matrix than on an equal projected area of a regular culture dish.
TABLE I Matrix No. cells/Cm 2 Level of confluency as observed by microscope Polypropylene 4 x 105 70% Polyester 6 x 105 60% Nunc TC. dish 4 x 104 100% Sheets of non-woven fabric were cut into 21 x 34 cm rectangles, which were attached as 'lines' to the inside of 850 cm2 corning roller bottles. Uncoated roller bottles were used as controls. The fabric lined bottles were each seeded with 1) 0.3 x 107, 2)1 x 107 and 3)1.5 x 107 cells. The uncoated bottles were seeded with 1.5 x 107 cells each. All bottles were then half-filled with medium, and cultures were carried out on a rotating Belleo Roller apparatus 0.5/rev/min. Medium was replaced with fresh medium at 2 day intervals.The uncoated bottle reached confluence, as judged by microscopic examination after 3 days and contained a cell count of 5.7 x 107 cells. The 'lined' bottles were cultured for an additional 5 days. DNA determinations showed that 3-5 x 108 cells were obtained in each fabric lined bottle, irrespective of the amount seeded.
4. Sheets 200 cm long and 21 cm wide of non-woven fabric were laminated to a polypropylene screen (1 mm opening, 0.6 mm thick). The laminate was rolled into a spiral and placed within a roller bottle against the inner surface to form a spiral lining 7 layers deep. The roller bottles were seeded each with 1.5 x 107 cells, and half filled with medium. The progress of culture was followed by removing periodically a piece of the liner, and the growth medium was replaced periodically (based on analysis of glucose and lactic acid) to avoid nutrient exhaustion. The cell proliferated with an average doubling time of 1.2 days and reached after 12 days approximately 4 x 109 cells per bottle.
5. Cell culture on non-woven fabrics in a flow-through reactor were tested in a laboratory scale assembly depicted in Figure 5. Polypropylene or polyester support matrix was introduced into the reactor chamber (Figure 5) in wither of the following forms. i) Stacked circles of a laminate of the unwoven fabric and polypropylene screens. Round holes, 3 mm diameter, were punched (1 or 5 holes per circle) in each circle to allow medium flow (Figure 4). ii) A rectangle of laminate was rolled into a tight spiral which fitted snugly into the reactor chamber (Figure 4).
The cells were seeded into the reactor with enough growth medium to cover the matrix. The reactor was closed and the reservoir was filled with medium. After 4 hours of static incubation, medium circulation was started. Pump speed was adjusted to give an initial medium residence time of 25 mins, and as the cells proliferated pumping rate was increased to decrease residence time to about 1 min. The reactor chamber was sampled periodically, by taking out a piece of support, and determining DNA. After 8 days of culture the cell density in the reactor chamber reached 2 x 106 cells/ml with stacked circles and nearly 7 x 106 cells/ml with the spiral.
6. Flocks of fibers of rayon (18 urn thick, 0.5 - 2 mm long), nylon (15 urn 0.5 - 1.5 mm) and acrylic (10 - 20u x 0.2 -1 mm) were treated as in Example 1. One tenth g. of each was layered on the bottem of 50 mm petri dishes, seeded with cells and covered with 3 ml of DMEM + 10% serum. The number of cells that attached to the fiber layer was determined after 24 hours. The attachment efficiency was 15-20% on the acrylic fibers, 35% on the rayon, and nearly 60% on the nylon fibers. A control with a regular tissue culture dish gave 70% attachment efficiency.
7. Sheets of non-woven fabric (400 cm2) were cut into small squares (approximately 3 x 3 mm) and loaded into Techne 200 ml culture vessel with 100 ml of medium. Bottles were seeded with 1 x 106, 5 X 106 and 1.5 X 107 cells each. Stirring was 30 rpm, and for the first 4 hours the stirrer was on for 30 min and off for 5 min.
After that stirring was continuous. On the third day after seeding 70 ml of medium were replaced with fresh medium and thereafter 35 ml were replaced daily. Cell counts were carried our daily by DNA determination.
Cell attachment determined 24 hours after seeding was on the average 67% (56-81%) independent of seeding density. The runs were continued for 4 days after seeding and cell doubling time was on the average about 32 hours. Final cell counts indicated that the cells in each bottle had increased approximately 10 times, and that the rate of increase was insensitive to low concentration of inoculum.
8. Two millimeter diameter microdiscs were punched from a non-woven fiber sheet composed of 1.5 devices per filament polyester fibers and 15 devices per filament hollow polypropylene fibers, using a heated die that thermally bonded the edges of the discs in the manner shown in Figure 2a giving the disc a doubly convex or lens-like appearance. The discs were then treated as in Example 1, and placed into Techne 200 ml stirred culture bottles at a concentration of 50 particles per ml in 100 ml of medium. IMR-90 human lung fibroblast cells were inoculated at a concentration of 105 cells/ml.
Stirring was intermittent and then continuous as in Example 7. Medium was replaced as in Example 7. After 8 days, cells were counted and were found to have a concentration of 4 x 106 cells per milliliter, proving that an inoculation of 2.5% of final concentration was feasible.
9. A spiral laminated structure comprised of two flattened, one-inch-wide, cellulose dialysis tubes (13); to strips of surface treated non-woven polyester fabric (11) (1 Oum fiber diameter); and four strips of polypropylene spacer screening (12) (0.6 um diameter monofilament, 1 mm opening) was assembled in the form shown in Figure 6 where, each flattened tube (13) had within itself a strip of spacer screening (12), and was bound on its external flat surfaces by a strip of non-woven fiber-grwoth matrix (11) and spacer screen (12). The entire assembly was placed in a sterile container (16) and imersed in growth medium (17) as shown in Figure 7.
The dialyses tubes were each 50 cm long. Nutritional medium without serum was pumped through one flattened tube at a linear flow rate of about 1 cm per second. A sterile mixture of air and 5% CO2 was pumped through the other flattened permeable spiral tube. By suitable means the discharge flow from the gas tube was restricted at two minute intervals so as to cause the spiral tube carrying the gas to periodically swell and contract so as to cause a gentle, reversible, periodic displacement of the growth medium in which the spiral is immersed.
The laminated spiral assembly of fiber growth matrix, spacers, and tube, was immersed in 100 ml of DMEM growth medium containing 10% serum. Hybridomas were inoculated into the serum containing growth medium at a density of 1.5 x 105 cells/ml. After nine days the cell concentration in the immersion medium had grown to above 107 cells/ml. The circulating medium contained no serum. The immersion growth medium contained serum and was perfused at a rate that replaced the serum once every 24 hours. After nine days, when full growth had been attained the immersion growth medium was changed to a production immersion medium that contained no serum. The perfusion rate was continued with removal of mono-clonal antibody from the immersion medium. The concentration of monoclonal antibody remained stable for 6 weeks at which time the experiment was stopped, although it could have continued.
The spiral assembly separated the growth medium, nutrient medium and gas channels, allowing each to be perfused separately which mass-transfer diffusive contact was maintained among the channels. Serum was conserved and antibody titer was maintained at an optimal level.
LEGENDS TO THE FIGURES Figures 1 A & B Fibroblasts grown on polyester sheets.
Discs of polyester sheets were cut to fit into 30 mm petri dish. Cells were seeded and allowed to proliferate for (A) 4 days (B) 12 days. The cells were then fixed and stained with gimza stain for microscopic obervation.
Figure 2 Matrix sheet (1) laminated to polypropylene screen (2).
Figure 2A Doubly convex suspension culture fibrous microdisc comprised of randomly oriented filaments of variety of polymers some of which are capable of thermal bonding, and some of which are hollow and open ended entrapping air or gas bubbles whose size and buoyancy is determined by external pressure in the suspension culture vessel. The thermally bonded edge-formed by stmping through a heated die or punch.
Figure 2B Hollow fiber showing gas bubbles trapped in lumen.
Figure 3 Spiral sheets of matrix inside roller bottle.
Matrix sheets (1), Polyproylene screen (2) Figure 4 Matrix sheets as packing in column.
A-circular -B. Spiral. Matrix sheets (1), Polypropylene screen (2).
Figure 5 Laboratory scale reactor with medium perfusion.
Figure 6 Spiral assembly of growth matrix and flatten ed permeable tubes carrying nutrient medium and air. Cell growth occurs in the matrix laminated ourside the flattened tubes.
Figure 7 Laminated spiral assembly as in Figure 6, shown inserted in sterile contained containing immersion growth medium, said container having suitable connections for perfusing all fluid channels.
Figure 7a Cross-section of laminated spiral assembly of Figure 6 and 7.
Figure 8 Laminated stack of growth matrix sheets interleaved with flattened medium and gas tubes, and separator screens.

Claims (32)

1. A matrix for use in cell cultivation in vitro providing a high-surface-area substrate, the effective surface of which is from 10 to about 100 times the area of same projected onto a plane surface, comprising a physiologically acceptable network of fibers having a porosity of from 40 to about 95% and a pores size of the order of 10 u to 100 p, or an open-pore foamed structure with a pore size of from about 10 u to 100 p, the overall height of the matrix being of the order of from 50 u to about 500 p.
2. A matrix according to claim 1, having a 3-dimensional structure which is a non-woven fabric from round, flat, non-round, or hollow fibers or combination of such fibers of the order of from 0.5 urn to 50 urn diameter or width.
3. A matrix according to claim 2, wherein the structure is composed of ribbon formed fibers of 2 urn to 20 urn width which may be crimped, and where the ratio of width to thickness is 2:1 or more.
4. A matrix according to claim 1, having an open-pore foamed polymer structure with pores of about 10 u to about 100 p and with a porosity of from 60 to 95%.
5. A matrix according to any of claims 1 to 4, bonded or laminated to a porous support sheet.
6. A matrix according to any of claims 1 to 5, in particle or flake form of from 1 mm2 to about 1 Omm2 projected surface area, and overrall height of 50 urn to about 250 m.
7. A matrix according to any of claims 1 to 6, wherein the surface is modified for increased cell attachment by subjecting same to a corona discharge, to a gaseous cold plasma (at low pressure and at a radio frequency) or where said surface is modified by coating with a suitable substance.
8. A matrix-sheet according to any of claims 1 to 6 wherein the surface of the matrix is modified for enhanced cell attachment by reaction with a chemical coupling agent, a derivating agent, or by antibodies to cell surface antigens.
9. A matrix-sheet according to any of claim 1 to 7, wherein the surface is given a net positive or net negative electric charge.
10. A matrix according to any of claims 1 to 7, where the surface of the components of the matrix is coated with poly-D-lysine.
11. A matrix according to any of claims 1 to 8, wherein the fiber material or foamed material is a polyester, a polyalkylene, PVC, polystyrene, collagen fibers, glass fibers, a natural fiber, or an insert metal.
12. A matrix-sheet according to any of claims 1 to 11 that is pleated, folded or spirally wound.
13. A system for in vitro cell culture comprising sequence of a matrix as claimed in any of claims 1 to 9 of up to about 260 p height, a separator sheet and a further such matrix sheet, etc; there being provided a desired number of matrix sheet and separators one above the other in stack form.
14. A system for in vitro cell culture according to claim 13, inserted into, or attached to, the surface of petri dishes, roller bottles, flasks or other container.
1 5. A system for in vitro suspension cell culture according to claim 13, comprising matrix particles, flakes or discs according to claim 6 suspended in a liquid nutrient medium.
16. A system for in vitro culture according to claims 1 3, comprising a column that contains a bed of loosely packed particles comprised of pieces of matrix-sheet and suitable separators or baffles to promote uniform flow of fluids through said bed.
17. A method of in vitro cell cultivation which comprises cultivating said cells on a matrix defined in any of claims 1 to 12 or 18-24 in a stack system defined in any of claims 13 to 16 or 25-28, means being provided for the supply of nutrient and for the removal of waste products.
18. A matrix according to claim 6 comprising of a combination of fibers of polymers having densities higher and lower than water density respectively, said combination having a buoyancy that is substantially neutral in the liquid nutrient medium in which said matrix is suspended.
19. A matrix according to claim 18, wherein said combination of fibers of polymer consists of polypropylene fibers and polyethylene terephthalate fibers having an effective specific gravity of about 1.001 to 1.04.
20. A matrix according to claim 18 wherein said combination of fibers consists of approximately 50 to 80 weight percent polypropylene fibers and about 20 to 50 weight percent polypropylene fiber.
21. A matrix according to claim 6 composed of a combination of fibers having solid cross-sections and hollow cross-sections said combination having a buoyancy that is substantially neutral in the liquid medium in which said matrix is suspended.
22. A matrix according to claim, 21 wherein all or a portion of the hollow fibers have at least one sealed end or obstructed lumen in which air or gas is entrapped and whose buoyancy in liquid medium is a function of the external pressure applied to said medium in the manner of an "Cartesian diver".
23. A system for in vitro suspension either comprising matrix particles according to claim 22, suspended in a liquid medium, wherein said matrix particles are repeatedly made to float and sink through said liquid medium by repeatedly lowering and raising the external pressure applied to said liquid medium.
24. A matrix according to claim 6 comprised of hollow fibers, where one or more has a filled lumen, having an effective specific gravity of about 1.001 to 1.04.
25. A system for in vitro high density culture or growth of cells that is comprised of layers of matrix sheets as hereinbefore described and within which cells are entrapped or anchored, and between which matrix sheet layers are interleaved flattened permeable or microporous tubular conduits through which nutrient medium is conducted, and other permeable microporous flattened tubular conduits serving as channels for air and other gases, said layered interleaved structures arranged in a stack or spiral that is immersed in nutrient medium contained in a suitable sterile housing for introducing and withdrawing cells and fresh and spent liquids and gases, and provided with means for monitoring temperature, pH, glucose concentration and other paramaters of the culture system, all cell growth occurring in the fluid medium outside the flattened, permeable sided, interlayered, tubular channels and largely on the interleaved layers of hereinbefore described matrix sheets.
26. A system according to claim 25, wherein the flattened, interleaved, tubular conduits are composed of permeable or microporous polymer film such as cellulose, polyester, polysulfone, poly halogenated ethylene and other halocarbons.
27. A system according to claim 25 or 26 wherein the fluid cell growth medium outside the flattened, permeable interleaved conduits is perfused.
28. A system according to claim 26, wherein the fluid, cell-growth medium outside the flattened permeable, interleaved polymer tubes, is agitated gently by the periodic increase and decrease of the volume of fluid within one or more of the flattened tubular conduits.
29. A matrix according to claim 1 substantially as hereinbefore described with reference to any one of the Examples.
30. A stack system according to claim 13 or 25 substantially as hereinbefore described with reference to any one of the Examples.
31. A method according to claim 17 substantially as hereinbefore described with reference to any one of the Examples.
32. A matrix or stack system according to any one of claims 1 to 16 or 18 to 28 substantially as hereinbefore described with reference to the accompanying drawings.
GB8614799A 1985-06-18 1986-06-18 A system for cell cultivation in vitro. Expired GB2178447B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL75554A IL75554A (en) 1985-06-18 1985-06-18 Matrix for cell cultivation in vitro

Publications (3)

Publication Number Publication Date
GB8614799D0 GB8614799D0 (en) 1986-07-23
GB2178447A true GB2178447A (en) 1987-02-11
GB2178447B GB2178447B (en) 1989-12-28

Family

ID=11056003

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8614799A Expired GB2178447B (en) 1985-06-18 1986-06-18 A system for cell cultivation in vitro.

Country Status (3)

Country Link
JP (1) JPH0829077B2 (en)
GB (1) GB2178447B (en)
IL (1) IL75554A (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263371A2 (en) * 1986-10-04 1988-04-13 Akzo N.V. Process and apparatus for animal cell culture
GB2221920A (en) * 1988-08-04 1990-02-21 Ion Tech Ltd Cell culture apparatus
US4937196A (en) * 1989-08-18 1990-06-26 Brunswick Corporation Membrane bioreactor system
EP0380610A1 (en) * 1988-05-23 1990-08-08 Univ Minnesota Bioreactor device.
WO1990010018A1 (en) * 1989-02-23 1990-09-07 Creative Biomolecules, Inc. Bone collagen matrix for implants
EP0435871A4 (en) * 1988-07-05 1991-05-14 Albert J Banes Floating cell culture device and method.
EP0451706A1 (en) * 1990-04-06 1991-10-16 Sakai Engineering Co., Ltd. Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein
EP0462426A1 (en) * 1990-06-01 1991-12-27 FIDIA S.p.A. Biocompatible perforated membranes and their use as artificial skin
EP0475303A2 (en) * 1990-09-07 1992-03-18 The Dow Chemical Company Growth of cells in hollow fibers in an agitated vessel
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
WO1992018609A1 (en) * 1991-04-12 1992-10-29 Vito Membranes with immobilized microorganisms thereon and/or therein, process for obtaining such membranes, reactor comprising said membranes and process involving the use of said membranes, in particular for the elimination of metals or the degradation of xenobiotic organic compounds
US5162114A (en) * 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5162225A (en) * 1989-03-17 1992-11-10 The Dow Chemical Company Growth of cells in hollow fibers in an agitated vessel
US5168058A (en) * 1987-04-03 1992-12-01 Yeda Research And Development Company, Ltd. Cell culture carriers and method of use
WO1993012877A1 (en) * 1991-12-20 1993-07-08 Allied-Signal Inc. Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals
US5254471A (en) * 1986-10-06 1993-10-19 Toray Industries, Inc. Carrier for cell culture
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
GB2252562B (en) * 1990-03-05 1994-04-20 Smith & Nephew Wound dressing comprising cultured cells
WO1994012614A1 (en) * 1992-11-25 1994-06-09 Cultor Ltd. Bioreactor with immobilized lactic acid bacteria and the use thereof
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
EP0671469A2 (en) * 1994-03-09 1995-09-13 Research Development Corporation Of Japan A medium-penetrating cell culture carrier and a culturing method and a device using this carrier
US5476783A (en) * 1992-03-23 1995-12-19 Koch Engineering Company, Inc. Bioreactor method of culturing and propagating cells with a woven motionless mixing element
US5501971A (en) * 1993-01-29 1996-03-26 New Brunswick Scientific Co., Inc. Method and apparatus for anchorage and suspension cell culture
US5502082A (en) * 1991-12-20 1996-03-26 Alliedsignal Inc. Low density materials having good compression strength and articles formed therefrom
US5508174A (en) * 1993-06-18 1996-04-16 The United States Of America As Represented By The Secretary Of The Air Force Method and micro roller bottle for in vitro exposure of cells to volatile chemicals
US5525710A (en) * 1991-12-20 1996-06-11 Alliedsignal Inc. Highly porous chitosan bodies
EP0743979A1 (en) * 1994-02-04 1996-11-27 Difco Laboratories Microbiological culture bottle, and method of making and using same
US5605835A (en) * 1988-05-23 1997-02-25 Regents Of The University Of Minnesota Bioreactor device with application as a bioartificial liver
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5702945A (en) * 1995-02-15 1997-12-30 Heraeus Instruments Gmbh Culture vessel for cell cultures on a carrier
US5776747A (en) * 1994-07-20 1998-07-07 Cytotherapeutics, Inc. Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
US5786215A (en) * 1987-05-20 1998-07-28 Baxter International Inc. Method for culturing animal cells
US5843431A (en) * 1994-07-20 1998-12-01 Cytotherapeutics, Inc. Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
US5955353A (en) * 1997-05-22 1999-09-21 Excorp Medical, Inc. Hollow fiber bioreactor with an extrafilament flow plug
AU714517B2 (en) * 1995-10-06 2000-01-06 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch Centrum Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system
US6013511A (en) * 1993-11-05 2000-01-11 Vito Precipitating metals or degrading xenobiotic organic compounds with membrane immobilized microorganisms
US6194198B1 (en) * 1998-11-24 2001-02-27 Bonno Koers Device for purifying gases, such as air in particular, or liquids, such as water in particular, and method for use with the device
US6495364B2 (en) 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
WO2003092982A2 (en) * 2002-05-04 2003-11-13 Membrana Gmbh Method for producing foamed polymer moulded bodies and foamed polymer moulded bodies
WO2004067733A1 (en) * 2003-01-31 2004-08-12 Himedica Limited Improvements in and relating to cell growth
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
WO2015155493A1 (en) * 2014-04-10 2015-10-15 J R Biomedical Limited Apparatus for the culture of parasites
US9896563B2 (en) 2005-08-10 2018-02-20 Toray Industries, Inc. Process for producing spongelike structure

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0746988B2 (en) * 1986-03-14 1995-05-24 日東電工株式会社 Cultivation method and culture device for adherent animal cells
JPH01179685A (en) * 1988-01-07 1989-07-17 Kirin Brewery Co Ltd Cell culture container and treatment of inner surface thereof
JPH07114686B2 (en) * 1989-06-26 1995-12-13 明治乳業株式会社 Circulating culture device
US6245345B1 (en) * 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
EP1788073B1 (en) * 2004-08-17 2013-11-06 Kyushu Institute of Technology Porous sheet member for cell culture and, utilizing the same, bioreactor and culturing method
WO2007095363A2 (en) * 2006-02-13 2007-08-23 Donaldson Company, Inc. Filter web comprising fine fiber and reactive, adsorptive or absorptive particulate
EP2018418B1 (en) * 2006-04-28 2014-12-10 Reinnervate Limited Substrate for the growth of cultured cells in three dimensions
WO2011108537A1 (en) 2010-03-02 2011-09-09 富士フイルム株式会社 Cell-supporting body and bone regeneration material
EP2575913B1 (en) 2010-05-25 2018-07-25 Cook Biotech Incorporated Methods, substrates, and systems useful for cell seeding of medical grafts
JP5868601B2 (en) * 2011-03-23 2016-02-24 フタムラ化学株式会社 Scaffolding material for liquid medium
CN106103821B (en) * 2014-02-14 2018-03-02 日产化学工业株式会社 Fiber manufacture composition containing active ester groups and the cell culturing rack material using the fiber
EP3452575A4 (en) * 2016-05-05 2020-03-11 Terumo BCT, Inc. Automated production and collection
JP7009957B2 (en) * 2017-11-28 2022-01-26 東洋紡株式会社 Cell culture container and cell culture device
KR20200118416A (en) * 2017-12-20 2020-10-15 유니버셀스 테크놀로지스 에스.에이. Bioreactor and related methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1387649A (en) * 1971-12-07 1975-03-19 Rhone Poulenc Sa Organosilicon polymer membrane
GB1491261A (en) * 1974-05-17 1977-11-09 Community Blood Council Cell-containing hollow fibres and use of same for metabolic processes
GB1514906A (en) * 1976-04-12 1978-06-21 Monsanto Co Cell culture reactor and method
GB2062006A (en) * 1979-09-18 1981-05-20 Asahi Chemical Ind Cultivating floating animal cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62502936A (en) * 1985-04-04 1987-11-26 ベラツクス コ−ポレ−シヨン Microsponges and bioreactors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1387649A (en) * 1971-12-07 1975-03-19 Rhone Poulenc Sa Organosilicon polymer membrane
GB1491261A (en) * 1974-05-17 1977-11-09 Community Blood Council Cell-containing hollow fibres and use of same for metabolic processes
GB1514906A (en) * 1976-04-12 1978-06-21 Monsanto Co Cell culture reactor and method
GB2062006A (en) * 1979-09-18 1981-05-20 Asahi Chemical Ind Cultivating floating animal cells

Cited By (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263371A3 (en) * 1986-10-04 1990-05-23 Akzo N.V. Process and apparatus for animal cell culture
EP0263371A2 (en) * 1986-10-04 1988-04-13 Akzo N.V. Process and apparatus for animal cell culture
US5254471A (en) * 1986-10-06 1993-10-19 Toray Industries, Inc. Carrier for cell culture
US5168058A (en) * 1987-04-03 1992-12-01 Yeda Research And Development Company, Ltd. Cell culture carriers and method of use
US5786215A (en) * 1987-05-20 1998-07-28 Baxter International Inc. Method for culturing animal cells
US5863758A (en) * 1988-04-08 1999-01-26 Stryker Corporation Nucleic acids encoding osteogenic proteins
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US6551995B1 (en) 1988-04-08 2003-04-22 Stryker Corporation Osteogenic devices
US5468845A (en) * 1988-04-08 1995-11-21 Stryker Corporation Antibodies to osteogenic proteins
US7176284B2 (en) 1988-04-08 2007-02-13 Stryker Corporation Osteogenic proteins
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US5958441A (en) * 1988-04-08 1999-09-28 Stryker Biotech Corporation Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith
US5605835A (en) * 1988-05-23 1997-02-25 Regents Of The University Of Minnesota Bioreactor device with application as a bioartificial liver
EP0380610A1 (en) * 1988-05-23 1990-08-08 Univ Minnesota Bioreactor device.
EP0380610A4 (en) * 1988-05-23 1991-12-18 Regents Of The University Of Minnesota Bioreactor device
US5981211A (en) * 1988-05-23 1999-11-09 Regents Of The University Of Minnesota Maintaining cells for an extended time by entrapment in a contracted matrix
EP0435871A4 (en) * 1988-07-05 1991-05-14 Albert J Banes Floating cell culture device and method.
EP0435871A1 (en) * 1988-07-05 1991-07-10 BANES, Albert J. Floating cell culture device and method
GB2221920A (en) * 1988-08-04 1990-02-21 Ion Tech Ltd Cell culture apparatus
US4975526A (en) * 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
WO1990010018A1 (en) * 1989-02-23 1990-09-07 Creative Biomolecules, Inc. Bone collagen matrix for implants
US5162114A (en) * 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5171574A (en) * 1989-02-23 1992-12-15 Stryker Corporation Bone collagen matrix for implants
US5162225A (en) * 1989-03-17 1992-11-10 The Dow Chemical Company Growth of cells in hollow fibers in an agitated vessel
US4937196A (en) * 1989-08-18 1990-06-26 Brunswick Corporation Membrane bioreactor system
GB2252562B (en) * 1990-03-05 1994-04-20 Smith & Nephew Wound dressing comprising cultured cells
EP0451706A1 (en) * 1990-04-06 1991-10-16 Sakai Engineering Co., Ltd. Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein
US6605117B2 (en) 1990-05-29 2003-08-12 Stryker Corporation Synthetic bone matrix
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US6468308B1 (en) 1990-05-29 2002-10-22 Stryker Corporation Synthetic bone matrix
US5650164A (en) * 1990-06-01 1997-07-22 Fidia S.P.A. Process for preparing artificial skin with biocompatible perforated membranes
US5326356A (en) * 1990-06-01 1994-07-05 Fidia S.P.A. Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts
EP0462426A1 (en) * 1990-06-01 1991-12-27 FIDIA S.p.A. Biocompatible perforated membranes and their use as artificial skin
US5658331A (en) * 1990-06-01 1997-08-19 Fidia S.P.A. Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts
EP0475303A3 (en) * 1990-09-07 1992-07-01 The Dow Chemical Company Growth of cells in hollow fibers in an agitated vessel
EP0475303A2 (en) * 1990-09-07 1992-03-18 The Dow Chemical Company Growth of cells in hollow fibers in an agitated vessel
WO1992018609A1 (en) * 1991-04-12 1992-10-29 Vito Membranes with immobilized microorganisms thereon and/or therein, process for obtaining such membranes, reactor comprising said membranes and process involving the use of said membranes, in particular for the elimination of metals or the degradation of xenobiotic organic compounds
US5541234A (en) * 1991-12-20 1996-07-30 Alliedsignal Inc. Process for making low density hydrogel materials having high surface areas
WO1993012877A1 (en) * 1991-12-20 1993-07-08 Allied-Signal Inc. Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals
US5502082A (en) * 1991-12-20 1996-03-26 Alliedsignal Inc. Low density materials having good compression strength and articles formed therefrom
US5494940A (en) * 1991-12-20 1996-02-27 Alliedsignal Inc. Low density materials having high surface areas and articles formed therefrom
US5525710A (en) * 1991-12-20 1996-06-11 Alliedsignal Inc. Highly porous chitosan bodies
US5476783A (en) * 1992-03-23 1995-12-19 Koch Engineering Company, Inc. Bioreactor method of culturing and propagating cells with a woven motionless mixing element
US5565361A (en) * 1992-03-23 1996-10-15 Koch Engineering Company, Inc. Bioreactor for culturing and propagating cells with a woven motionless mixing element
WO1994012614A1 (en) * 1992-11-25 1994-06-09 Cultor Ltd. Bioreactor with immobilized lactic acid bacteria and the use thereof
US5635368A (en) * 1992-11-25 1997-06-03 Cultor Ltd. Bioreactor with immobilized lactic acid bacteria and the use thereof
US5501971A (en) * 1993-01-29 1996-03-26 New Brunswick Scientific Co., Inc. Method and apparatus for anchorage and suspension cell culture
US5508174A (en) * 1993-06-18 1996-04-16 The United States Of America As Represented By The Secretary Of The Air Force Method and micro roller bottle for in vitro exposure of cells to volatile chemicals
US6013511A (en) * 1993-11-05 2000-01-11 Vito Precipitating metals or degrading xenobiotic organic compounds with membrane immobilized microorganisms
EP0743979A1 (en) * 1994-02-04 1996-11-27 Difco Laboratories Microbiological culture bottle, and method of making and using same
EP0743979A4 (en) * 1994-02-04 1997-03-12 Difco Lab Microbiological culture bottle, and method of making and using same
US5736399A (en) * 1994-03-09 1998-04-07 Research Development Corporation Of Japan Medium-penetrating cell culture carrier, a culturing method and a device using this carrier
EP0671469A2 (en) * 1994-03-09 1995-09-13 Research Development Corporation Of Japan A medium-penetrating cell culture carrier and a culturing method and a device using this carrier
EP0671469A3 (en) * 1994-03-09 1996-12-18 Japan Res Dev Corp A medium-penetrating cell culture carrier and a culturing method and a device using this carrier.
US5776747A (en) * 1994-07-20 1998-07-07 Cytotherapeutics, Inc. Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
US5840576A (en) * 1994-07-20 1998-11-24 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5833979A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5858747A (en) * 1994-07-20 1999-01-12 Cytotherapeutics, Inc. Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
US5795790A (en) * 1994-07-20 1998-08-18 Cytotherapeutics, Inc. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
US5843431A (en) * 1994-07-20 1998-12-01 Cytotherapeutics, Inc. Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
US5935849A (en) * 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6392118B1 (en) 1994-07-20 2002-05-21 Neurotech S.A. Mx-1 conditionally immortalized cells
US5853717A (en) * 1994-07-20 1998-12-29 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5702945A (en) * 1995-02-15 1997-12-30 Heraeus Instruments Gmbh Culture vessel for cell cultures on a carrier
US6495364B2 (en) 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
US6372495B1 (en) * 1995-10-06 2002-04-16 Seed Capital Investments-2 (Sci-2) B.V. Bio-artificial organ containing a matrix having hollow fibers for supplying gaseous oxygen
AU714517B2 (en) * 1995-10-06 2000-01-06 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Academisch Medisch Centrum Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in bio-artificial liver system
US5955353A (en) * 1997-05-22 1999-09-21 Excorp Medical, Inc. Hollow fiber bioreactor with an extrafilament flow plug
US6194198B1 (en) * 1998-11-24 2001-02-27 Bonno Koers Device for purifying gases, such as air in particular, or liquids, such as water in particular, and method for use with the device
WO2003092982A2 (en) * 2002-05-04 2003-11-13 Membrana Gmbh Method for producing foamed polymer moulded bodies and foamed polymer moulded bodies
WO2003092982A3 (en) * 2002-05-04 2004-12-09 Membrana Gmbh Method for producing foamed polymer moulded bodies and foamed polymer moulded bodies
US7429420B2 (en) 2002-05-04 2008-09-30 Membrana Gmbh Method for producing foamed polymer molded bodies and said foamed polymer molder bodies
WO2004067733A1 (en) * 2003-01-31 2004-08-12 Himedica Limited Improvements in and relating to cell growth
US9896563B2 (en) 2005-08-10 2018-02-20 Toray Industries, Inc. Process for producing spongelike structure
WO2015155493A1 (en) * 2014-04-10 2015-10-15 J R Biomedical Limited Apparatus for the culture of parasites

Also Published As

Publication number Publication date
IL75554A (en) 1993-01-14
JPS62122586A (en) 1987-06-03
IL75554A0 (en) 1985-10-31
JPH0829077B2 (en) 1996-03-27
GB2178447B (en) 1989-12-28
GB8614799D0 (en) 1986-07-23

Similar Documents

Publication Publication Date Title
US5266476A (en) Fibrous matrix for in vitro cell cultivation
GB2178447A (en) A matrix for cell cultivation in vitro
CA2244659C (en) Biological reactor for the cultivation of cells
US5149649A (en) Multi-layered porous hollow fiber membrane for use in cell culture
US5786215A (en) Method for culturing animal cells
JP3246664B2 (en) Scaffold and method for culturing suspended cells and apparatus therefor
AU777290B2 (en) Culture chamber
US5376548A (en) Bioreactor apparatus
US6228607B1 (en) Bioreactor
CA1071556A (en) Cell culture reactor system
EA009716B1 (en) Cell cultivation method
US20040067585A1 (en) Cell cultivation surface and method of making the same
EP1425379B1 (en) Method and structure for growing living organic tissue
JP2024501108A (en) Packed bed bioreactor with controlled area porosity
JP2619885B2 (en) Cell culture method and device
US4833081A (en) Bioreactor having cells in beads in a matrix
DE102010005415B4 (en) Method and device for the dynamic expansion and / or differentiation of suspended primary cells or stem cells of human and animal origin
JP4262695B2 (en) Membrane biodevice and bioreactor
JP3139794B2 (en) Hollow fiber membrane cell culture device
JP2001178445A (en) Carrier for culturing three-dimensional animal cell and three-dimensional animal cell
JPH0585156B2 (en)
JPH0568230B2 (en)
Kawakatsu et al. Hydroxyapatite-pulp composite fiber sheet bed: A new material for the immobilization of CHO-K1 cells
JPH0352954B2 (en)
GB2338243A (en) Macro carrier for cell culture

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20060617